News | April 12, 2025
Morepen to add 1,000 medical representatives
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
The company reported lifetime high EBIDTA of Rs. 250 crores
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Subscribe To Our Newsletter & Stay Updated
